anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Matinas BioPharma · pitchdeck

Matinas BioPharma | Investor Presentation Deck | 29 slides

29 pages · 5 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

Matinas BioPharma | Investor Presentation Deck | 29 slides

Matinas BioPharma · 2024-03
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 12 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 1 slides 100% 1/1 slides 100% 1/1 slides · 10 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Agitate (Make it worse) 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Solution (Provide relief) 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Situation & Context 4 slides 100% 4/4 slides 100% 4/4 slides · 19 hits
— 0/4 slides
50% 2/4 slides 50% 2/4 slides 100% 4/4 slides 100% 4/4 slides Evidence & Proof 5 slides 100% 5/5 slides 100% 5/5 slides · 25 hits
— 0/5 slides
60% 3/5 slides 20% 1/5 slides 100% 5/5 slides 100% 5/5 slides

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a process-flow structure to connect the technology (LNCs) to current clinical validation (MAT2203) and future pipeline expansion.present_solution
Open slide detailBeat · Situation & ContextLoop · Golden Circle
04
Includes scientific illustration of molecular structure and bulleted list of key benefits.present_solution
Open slide detailBeat · Situation & ContextLoop · Golden Circle
05
The slide uses a two-part framework to explain the biological mechanism: Targeting (left) and Delivery (right).present_solution
Open slide detailBeat · Situation & ContextLoop · Golden Circle
06
transition
Open slide detailBeat · Situation & ContextLoop · Golden Circle
07
Uses authority-citation to establish the urgency of the problem.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
08
Uses a before-after-bridge style logic to frame the solution.present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
09
show_traction
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
10
This is a validation slide showing scientific credibility through peer-reviewed publication.show_traction
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
11
The slide uses a human silhouette as a central anchor to map specific medical conditions to anatomical locations.show_traction
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
12
Highlights clinical success in patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.show_traction
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
13
Includes a timeline of clinical events and longitudinal charts for Creatinine and Potassium levels.illustrate_case
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
14
The slide highlights the limitations of current first-line azole treatments and identifies a specific patient sub-segment with high unmet need.frame_problem
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
15
Mentions specific regulatory pathways (LPAD, QIDP, ODD, Fast-Track) and the ORALTO trial.plan_implementation
Open slide detailLoop · Quick Win Big Bet
16
The slide outlines a non-inferiority trial design comparing oral MAT2203 to IV LAMB/SoC.plan_implementation
Open slide detailLoop · Quick Win Big Bet
17
Uses a combination of an additive equation for the value prop and a chevron-based timeline for lifecycle management.present_solution
Open slide detailLoop · Quick Win Big Bet
18
transition
Open slide detailLoop · Quick Win Big Bet
19
The slide uses a process-flow style diagram to map delivery mechanisms to therapeutic areas.present_solution
Open slide detailLoop · Quick Win Big Bet
20
The chart shows a clear time-dependent increase in cellular uptake across four cell types (Neutrophils, Monocytes, mDC, pDC).show_traction
Open slide detailLoop · Quick Win Big Bet
21
Data shows dose-dependent or treatment-specific reduction in disease markers compared to IMQ-only control.show_traction
Open slide detailLoop · Quick Win Big Bet
22
Includes a line chart for disease activity index over 14 days and two bar charts for TNFa tissue mRNA and serum TNFa levels at day 14.analyze_data
Open slide detailLoop · Quick Win Big Bet
23
Uses a before-after-framing style to contrast healthy vs tumor cell interaction.present_solution
Open slide detailLoop · Quick Win Big Bet
24
The slide includes a timeline of the study and a legend for the treatment groups.show_traction
Open slide detailLoop · Quick Win Big Bet
25
The slide uses a line chart to show weight loss over 22 days, highlighting that IV-Docetaxel causes significant weight loss (toxicity) while oral LNC-Docetaxel show_traction
Open slide detailLoop · Quick Win Big Bet
26
The slide uses a two-column layout to contrast oncology and inflammation results, followed by a summary box of platform capabilities.show_traction
Open slide detailLoop · Quick Win Big Bet
27
The slide uses a three-column icon-based layout to summarize IP and regulatory assets.present_solution
Open slide detailLoop · Quick Win Big Bet
28
other
Open slide detailLoop · Quick Win Big Bet
29
The slide combines a financial summary with a timeline of milestones and a strategic outlook.summarize
Open slide detailLoop · Quick Win Big Bet